Adeno-Associated Virus (AAV) Assays

We deliver a comprehensive suite of AAV-based assays to support gene therapy development, preclinical studies, and translational research. Our services include pre-existing immunogenicity testing to evaluate baseline immune responses to AAV serotypes, biodistribution studies to assess vector spread and tissue targeting, and neutralization assays to measure the presence and potency of antibodies that could impact therapeutic efficacy. Each assay can be customized to meet specific study requirements, and our rigorous methodologies ensure reliable, high-quality data that accelerate vector optimization and support informed decision-making throughout the development process.​